Jack Hidary

CEO, SandboxAQ

· tracked since Jun 2026

Calls

Win Rate

100.0%

return

+7.5%

Calls 1 1 Posts tracked · 0.1/day

Calls

7d 0

30d 1

90d 1

Best Calls

XBI long +7.5%

Worst Calls

No live losers yet

Most Mentioned

XBI ×1

Recent Calls

XBI long 2 weeks ago

Win Rate 100% Long 1 Short 0

Win Rate

7d 100%

30d —

90d —

Average Return +7.5% Long Return +7.5% Short Return -

Average Return

7d +6.9%

30d —

90d —

Loading charts...

Ticker

Side

Mentions

Opened

Entry

P&L

Thesis

Theme

Source

XBI SPDR S&P... SPDR S&P Biotech ETF

Long

Jun 23

$147.98

+7.5%

AI accelerates drug discovery, bullish for biotech.

AI-driven physics-based models (Nvidia BioNeMo + SandboxAQ AQ state) enable virtual screening of GPCR-targeting drug candidates, cutting discovery time from years/decades to weeks/months and improving success rates. This breakthrough transforms drug discovery, making biotech and healthcare a massive addressable sector with strong tailwinds as drug companies, biotech firms, and researchers adopt these tools.

Thematic ETFs

YOUTUBE

Showing 1 of 1 picks · sorted by mentions

Jack Hidary has 1 trade ideas tracked on Buzzberg across 1 tickers since June 2026. Most covered: XBI.